Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis

Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell sampl...

Full description

Saved in:
Bibliographic Details
Published inCell research Vol. 21; no. 11; pp. 1551 - 1563
Main Authors Wang, Yu-Chieh, Nakagawa, Masato, Garitaonandia, Ibon, Slavin, Ileana, Altun, Gulsah, Lacharite, Robert M, Nazor, Kristopher L, Tran, Ha T, Lynch, Candace L, Leonardo, Trevor R, Liu, Ying, Peterson, Suzanne E, Laurent, Louise C, Yamanaka, Shinya, Loring, Jeanne F
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.11.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell samples, and identified a small group of lectins with distinctive binding signatures that were sufficient to distinguish hPSCs from a variety of non-pluripotent cell types. These specific biomarkers were shared by all the 12 human embryonic stem cell and the 14 human induced pluripotent stem cell samples examined, regardless of the laboratory of origin, the culture conditions, the somatic cell type reprogrammed, or the reprogramming method used. We demonstrated a practical application of specific lectin binding by detecting hPSCs within a differentiated cell population with lectin-mediated staining followed by fluores- cence microscopy and flow cytometry, and by enriching and purging viable hPSCs from mixed cell populations using lectin-mediated cell separation. Global gene expression analysis showed pluripotency-associated differential expres- sion of specific fucosyltransferases and sialyltransferases, which may underlie these differences in protein glycosy- lation and lectin binding. Taken together, our results show that protein glycosylation differs considerably between pluripotent and non-pluripotent cells, and demonstrate that lectins may be used as biomarkers to monitor pluripo- tency in stem cell populations and for removal of viable hPSCs from mixed cell population
Bibliography:Rapid and dependable methods for isolating human pluripotent stem cell (hPSC) populations are urgently needed for quality control in basic research and in cell-based therapy applications. Using lectin arrays, we analyzed glyco- proteins extracted from 26 hPSC samples and 22 differentiated cell samples, and identified a small group of lectins with distinctive binding signatures that were sufficient to distinguish hPSCs from a variety of non-pluripotent cell types. These specific biomarkers were shared by all the 12 human embryonic stem cell and the 14 human induced pluripotent stem cell samples examined, regardless of the laboratory of origin, the culture conditions, the somatic cell type reprogrammed, or the reprogramming method used. We demonstrated a practical application of specific lectin binding by detecting hPSCs within a differentiated cell population with lectin-mediated staining followed by fluores- cence microscopy and flow cytometry, and by enriching and purging viable hPSCs from mixed cell populations using lectin-mediated cell separation. Global gene expression analysis showed pluripotency-associated differential expres- sion of specific fucosyltransferases and sialyltransferases, which may underlie these differences in protein glycosy- lation and lectin binding. Taken together, our results show that protein glycosylation differs considerably between pluripotent and non-pluripotent cells, and demonstrate that lectins may be used as biomarkers to monitor pluripo- tency in stem cell populations and for removal of viable hPSCs from mixed cell population
Yu-Chieh Wang , Masato Nakagawa3, Ibon Garitaonandia Ileana Slavin1' 2 Gulsah Altun, Robert M Lacharite Kristopher L Nazor1' 2, Ha T Tran1' 2 Candace L Lynch, Trevor R Leonardo, Ying Liu, Suzanne E Peterson Louise C Laurent, 7, Shinya Yamanaka , 6, Jeanne F Loring, The Scripps Research Institute, Department of Chemical Physiology, La Jolla, CA 92037, USA; 2The Scripps Research Institute, Center for Regenerative Medicine, 10550 N. Torrey Pines Rd, SP-3021, La Jolla, CA 92037, USA," 3Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan; 4Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan; 5Japan Science and Technology Agency, Yamanaka iPS Cell Special Project, Kawaguchi, Japan; 6Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158-2261, USA; 7Department of Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA
31-1568/Q
lectins; glycosylation; pluripotency biomarkers; human pluripotent stem cell; induced pluripotent stem cells; em- bryonic stem cells
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1001-0602
1748-7838
1748-7838
DOI:10.1038/cr.2011.148